May 03,2018

Virta Health Aiming to Eradicate Type 2 Diabetes in Indiana with Announcement of New Two Commercial Partnerships

Virta Health, the first company with a clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) and other chronic metabolic diseases without the use of medications or surgery, today announced new commercial partnerships with Tippecanoe County Government, Indiana and the City of Lafayette, Indiana. The two alliances expand Virta Health’s presence in the region and provide access to the Virta Treatment as a fully-covered healthcare benefit to employees of Tippecanoe County Government and the City of Lafayette Government.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 30,2018

Nemaura Medical Signs Joint Collaboration Agreement for European Commercialization

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced that it has entered in to a definitive joint Collaboration Agreement with Dallas Burston Ethitronix (DBE) to commercialize sugarBEAT® in the European Economic Area (EEA).

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Jul 09,2018

Insulet Partners with the International Diabetes Federation Europe to Support Advocacy Activities Across the Continent

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has entered into a partnership with the European Region of the International Diabetes Federation (IDF Europe) to collaborate on regional advocacy activities. This partnership provides broader access for Insulet to more closely engage with the European diabetes community.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Aug 29,2018

Senseonics Announces Partnership with Beyond Type 1

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and Beyond Type 1, the world’s largest diabetes community on social media, today announced they are joining forces. Through an agreement making the Eversense® CGM the exclusive worldwide presenting sponsor of the Type One Run – a global network of running groups for people with type 1 diabetes – Senseonics will be partnering with Beyond Type 1 to build support, community, and awareness for those affected by type 1 diabetes through running.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Oct 17,2018

CVS Health to Embark on Pilot Program to Combat Diabetes in Medically Underserved Atlanta Neighborhoods

CVS Health announced today that it is embarking on a pilot project in the Tri-Cities area of Atlanta, Georgia, aimed at addressing diabetes in medically underserved communities with chronically high rates of this disease. In collaboration with Rimidi, Inc., a digital health company, and select community organizations, CVS Health will work to heighten awareness of diabetes and improve access to care among Tri-Cities area residents. Together with community organizations, Rimidi and CVS Health will enroll residents onto the Rimidi platform and engage them in the diabetes education and support services offered through the pilot.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 12,2018

DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program, powered by Dario, to Giant Eagle's consumers through the pharmacy's 214 locations.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 20,2018

Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, today announced that it has signed an exclusive license and distribution agreement with Al-Danah Medical Co. for the commercial launch of sugarBEAT® in Qatar in readiness for 2019 launch.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 12,2018

DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, announced today that Toronto-based LMC Healthcare, Canada's largest specialist care provider in diabetes and endocrinology, will work with Dario who will provide digital content and coaching services across Canada for patients with diabetes. LMC has 11 clinics and 19 clinical research sites that provide care to over 39,000 patients with diabetes in Canada.

COLLABORATION PARTNERSHIP

#institution

#coaching

View Analyst & Ambassador Comments
Go to original news
Apr 14,2017

Purdue, Virta Health Partner In New Approach To Treat Type 2 Diabetes

Purdue University, one of the nation’s leading research universities, and Virta Health, a company founded by a world-class team of doctors and scientists, announced today a new partnership to offer its online type 2 diabetes clinic as a covered health benefit to its employees and their dependents. The partnership comes on the heels of a peer-reviewed study.

COLLABORATION PARTNERSHIP

#institution

#virtual care

#coaching

View Analyst & Ambassador Comments
Go to original news
Jul 24,2017

DarioHealth Announces Strategic Partnership with CCS Medical

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, today announced that it has entered into a strategic agreement with CCS Medical and their LivingConnected clinical program. Through this strategic agreement and proprietary API, DarioHealth is partnering with CCS Medical by providing live data access to CCS Medical for patients that join the LivingConnected clinical program using the DarioHealth native smartphone app. In addition, CCS Medical will take an active role in the DarioHealth Insurance Provider Network, thereby further growing DarioHealth's expansion into the insurance reimbursement option launched earlier this year.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION